Search

everythinglearnresearchcommunity

for

Search:↓

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

PRP and cell therapies may help with hair loss, but more research is needed.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Topical vitamin D is effective in treating vitiligo with few side effects.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Cynomorium songaricum has many health benefits and could help with hair regrowth.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Physical activity, height, and smoking affect prostate cancer risk.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.